Can green tea extract promote intestinal health and help reduce blood sugar levels?

Clinical evidence shows that the green tea extract (GTE) rich in catechins can help improve the function of intestinal barriers and reduce the systemic inflammation of the intestinal and body.近日，一篇发表在国际杂志Current Developments in Nutrition上题为“Catechin-Rich Green Tea Extract Reduced Intestinal Inflammation and Fasting Glucose in Metabolic Syndrome and Healthy Adults: A Randomized, Controlled, Crossover Trial”的研究报告中，来自宾夕法尼亚Scientists from institutions such as state universities and other institutions have studied by studying people carrying a group of heart disease risk factors, and found that the time to consume green tea extract may be reduced by reducing the inflammation and "intestinal leakage" of the body, thereby reducing the body's blood sugar Level and improve the intestinal health of the body.

Image source: https://academic.oup.com/cdn/article/6/supplement_1/981/6606956? Login = true

This study is the first time that researchers have evaluated whether health risks related to metabolic syndrome can be reduced by the intestinal anti -inflammatory benefits of green tea.

Researchers Richard Bruno said that research evidence shows that a large number of inges in green tea or the level of good cholesterol, blood sugar and triglycerides in the body, but there is no evidence to associate its intestinal health benefits with other health factors.

Researchers conducted relevant clinical trials on 40 individuals. Earlier, they were published in the research report in The Journal of Nutritional BioChemistry. The improvement of health is linked.

In this latest study, researchers have found that green tea extract can help reduce blood sugar, intestinal inflammation and permeability, which may be an unexpected discovery.

Researcher Bruno said that this may tell us that in one month, we can help the people of metabolic syndrome and healthy individuals reduce their body's blood sugar, and the reduction of blood sugar levels seems to decrease with intestinal leakage levels and the level of intestinal leakage and the level of intestinal leakage and The level of inflammation is related to whether it is healthy.

Patients with metabolic syndrome are diagnosed with at least three factors with five factors, which will increase the risk of the body's heart disease, diabetes, and other health problems. These factors include too many abdominal fat, hypertension, and lower beneficial beneficial cholesterol. , High -level empty blood glucose and triglyceride (a kind of fat in the blood). The difficulty of these risk factors for metabolic syndrome is that it often only changes slightly and does not require drug management, but it still causes huge risks to health. Most doctors suggest to lose weight and exercise, but unfortunately, we know that most people may not be able to follow the adjustment of lifestyle because of multiple reasons. Our research work aims to provide people with a new food -based tool for food -based tools. Help the risk of managing metabolic syndrome or reverse the occurrence of metabolic syndrome.

Participants participating in the study include 21 patients with metabolic syndrome and 10 healthy adults. These participants have taken candy with green tea extract containing catechins for 28 consecutive days. The daily dose is equivalent to five glasses of green tea. In the blind random cross -test, all participants took another 28 days to take placebo, and did not take any supplements between two times. Researchers confirm that all participants follow the suggestions to follow the lower levels of polyphenol diet during the placement of placebo and green tea extract, including fruits, vegetables, green tea, and natural antioxidants. It can be attributed to the separate effects of green tea.

The research results show that compared with the level after intake of placebo, all participants have a significantly low level of empty blood glucose level after ingestion of green tea extracts. After further analysis, the researchers have found that all participants have been in the treatment of green tea therapy after green tea therapy. The reduction of intestinal inflammation may be reducing the level of inflammatory protein in the stool sample, and after using a technology to evaluate the sugar ratio in the urine sample The transparency of the small intestine may decrease favorable. Intestinal permeability, that is, intestinal leakage, can cause intestinal bacteria and related toxic compounds to enter the blood, and stimulate low -level chronic inflammation.

Researcher Bruno pointed out that the absorption of intestinal derivatives is considered to be the starting factor that induces obesity and insulin resistance, and this may be the core of human heart metabolic diseases. If it can improve the integrity of the intestine and reduce intestinal leakage, Researchers may not only slow down the heart metabolic disease caused by low -level inflammation, but also potentially reverse these diseases.

At present, researchers have not tried to cure patient's metabolic syndrome in a month, but based on their understanding of causal factors behind metabolic syndrome, green tea may play a role at least part of the intestinal level, so as to be on the intestinal level, thereby It can slow down the risk of metabolic syndrome. At present, researchers are analyzing the level of microbial community in the intestine and bacterial -related toxins in the intestinal tract of participants. Primitive source:

Joanna Hodges, Min Zeng, Sisi Cao,et al.Catechin-Rich Green Tea Extract Reduced Intestinal Inflammation and Fasting Glucose in Metabolic Syndrome and Healthy Adults: A Randomized, Controlled, Crossover Trial,Current Developments in Nutrition(2022). DOI: 10.1093 /cdn/nzac068.010

Priyankar Dey,Geoffrey Y.Sasaki,Ping Wei，et al.Green tea extract prevents obesity in male mice by alleviating gut dysbiosis in association with improved intestinal barrier function that limits endotoxin translocation and adipose inflammation,The Journal of Nutritional Biochemistry(2019). Doi: 10.1016/j.jnutbio.2019.01.017

- END -